ASSEMBLY BIOSCIENCES, INC.
Key Highlights
- Trades on The Nasdaq Global Select Market under the ticker symbol ASMB.
- Designated as a "Non-accelerated filer" and a "Smaller reporting company," offering regulatory flexibility.
Financial Analysis
ASSEMBLY BIOSCIENCES, INC. Annual Report - How They Did This Year
Hey there! Let's chat about ASSEMBLY BIOSCIENCES, INC. and their performance this past year. We'll break it down so you can easily see if they're heading in a good direction for your investment.
Okay, we're looking at their official annual report (a 10-K filing). This report covers the fiscal year ending December 31, 2025. Companies use it to tell investors how they're doing.
First off, ASSEMBLY BIOSCIENCES, INC. trades on The Nasdaq Global Select Market under the ticker symbol ASMB.
Looking at their size, their 'public float' was about $97.8 million as of June 30, 2025. This is the stock available for everyday investors to trade. It excludes shares held by company insiders or large controlling investors. This size usually means it's a smaller company. Smaller companies can have more volatile stock prices because fewer shares are actively traded. Larger companies often have more stable prices.
ASSEMBLY BIOSCIENCES, INC. is a "Non-accelerated filer" and a "Smaller reporting company." The SEC gives these labels. They mean the company's public float was under $700 million (non-accelerated) and also under $250 million (smaller reporting company) as of the last business day of its most recent second fiscal quarter. Because of these labels, the company follows different reporting rules compared to larger companies, including exemptions from some executive pay rules. This status often indicates a newer or smaller company.
Keep these foundational points in mind as you explore their full financial picture to make an informed investment decision.
Risk Factors
- Smaller companies like ASMB can experience more volatile stock prices due to fewer actively traded shares.
- Its status as a "Smaller reporting company" often indicates a newer or smaller company, which may carry inherent risks.
Why This Matters
The 10-K is crucial for investors to understand a company's health. For ASSEMBLY BIOSCIENCES, INC., this report provides foundational details like its market listing on The Nasdaq Global Select Market and its ticker ASMB, which are essential for any potential investment.
The company's classification as a "Non-accelerated filer" and "Smaller reporting company" is particularly significant. This status means it operates under different SEC reporting rules, including exemptions from certain executive pay disclosures. While offering regulatory flexibility, it also implies a smaller market capitalization and potentially less comprehensive public information compared to larger entities, which investors must factor into their due diligence.
The public float of $97.8 million as of June 30, 2025, further reinforces its smaller company status. This metric, along with the reporting classifications, signals that ASMB's stock might experience higher volatility. Understanding these structural characteristics upfront is vital for investors to accurately assess risk and potential returns before delving into the detailed financial performance.
Financial Metrics
Learn More
About This Analysis
AI-powered summary derived from the original SEC filing.
Document Information
SEC Filing
View Original DocumentAnalysis Processed
March 20, 2026 at 02:04 AM
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.